An lab discovers novel nasal treatment for influenza
New data from researchers at the Brown Foundation Institute of Molecular Medicine exploring novel therapeutic approaches to treating Influenza A viruses has been published in Nature Communications. The paper, titled “An intranasally administered IgM protects against antigenically distinct subtypes of influenza…
Chandra claims top honors at AANS meeting
Ankush Chandra, MD, fifth-year resident in the Vivian L. Smith Department of Neurosurgery, earned top honors at the 2025 American Association of Neurological Surgeons Annual Scientific Meeting, one of the largest neurosurgical gatherings in the world with over 5,000 attendees….
Lee’s lab discovers nanocarrier to fight GBM
A recent study from researchers at McGovern Medical School discovered a novel engineered exosome model to help deliver therapeutic treatments to glioblastoma tumors, which could potentially enhance treatments for a notoriously fatal cancer. Findings from the study, led by Tae…
Study uncovers RNA changes in Alzheimer’s disease
Researchers at McGovern Medical School have gained insights about what happens inside brain cells during Alzheimer’s disease (AD), a devastating neurodegenerative disorder. Their findings, published in the journal Nature Communications on June 6, could help scientists better understand and eventually…
Link between heart attack severity and circadian rhythm unveiled
The molecular mechanism behind why heart attacks can vary in severity depending on the time of day has been uncovered by researchers at UTHealth Houston, potentially paving the way for innovative treatments that align with the natural circadian rhythm. The…
University researchers receive more than $5 million from CPRIT
Three UTHealth Houston researchers, including two from McGovern Medical School, received more than $5 million in funding from the Cancer Prevention and Research Institute of Texas (CPRIT), furthering the state’s mission to prevent and treat cancer through innovative science and…
McGovern shines at Health Science Education conference
McGovern Medical School was well-represented at the 2025 Innovations in Health Science Education 21st Annual Conference for The University of Texas System Kenneth I. Shine, MD, Academy of Health Science Education, with 40 attendees and a multitude of grant and…
Novel nanoscintillator concept leads to improved outcomes in pancreatic cancer
Research from the lab of Sunil Krishnan, MD, professor and John P. and Kathrine G. McGovern Distinguished Chair in the Vivian L. Smith Department of Neurosurgery, seeking to push the limits of light-activated therapies used to kill cancer cells has…
Common genetic variants linked to drug-resistant epilepsy
Certain common genetic changes might make some people with focal epilepsy less responsive to seizure medications, according to a new global study led by researchers from UCL in London and UTHealth Houston. Focal epilepsy is a condition where seizures start…
Human placenta stress response to maternal COVID-19 infection reinforces maternal-fetal barrier
A study published in the American Journal of Obstetrics & Gynecology by researchers at UTHealth Houston, Baylor College of Medicine and collaborating institutions reveals that maternal COVID-19 infection triggers distinct stress responses in the placenta, including upregulation of preeclampsia-associated genes. The stress…